Literature DB >> 29177538

Invited editorial for the paper by Silvoniemi et al. "Repeatability of tumor hypoxia imaging using [18F]EF5 PET/CT in head and neck cancer." in this issue of EJNMMI.

Cameron J Koch1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29177538     DOI： 10.1007/s00259-017-3889-8

Source DB:  PubMed          Journal:  Eur J Nucl Med Mol Imaging        ISSN： 1619-7070            Impact factor:   9.236


× No keyword cloud information.
  17 in total

1.  Radiation dosimetry and biodistribution of the hypoxia tracer (18)F-EF5 in oncologic patients.

Authors:  Lilie L Lin; Antti Silvoniemi; James B Stubbs; Ramesh Rengan; Sami Suilamo; Olof Solin; Chaitanya Divgi; Olli Eskola; Jonathan M Sorger; Michael G Stabin; Alexander Kachur; Stephen M Hahn; Tove J Grönroos; Sarita Forsback; Sydney M Evans; Cameron J Koch; Heikki Minn
Journal:  Cancer Biother Radiopharm       Date:  2012-08-16       Impact factor: 3.099

2.  Evidence for acutely hypoxic cells in mouse tumours, and a possible mechanism of reoxygenation.

Authors:  J M Brown
Journal:  Br J Radiol       Date:  1979-08       Impact factor: 3.039

3.  Hypoxia and VEGF mRNA expression in human tumors.

Authors:  L S Ziemer; C J Koch; A Maity; D P Magarelli; A M Horan; S M Evans
Journal:  Neoplasia       Date:  2001 Nov-Dec       Impact factor: 5.715

4.  High reproducibility of tumor hypoxia evaluated by 18F-fluoromisonidazole PET for head and neck cancer.

Authors:  Shozo Okamoto; Tohru Shiga; Koichi Yasuda; Yoichi M Ito; Keiichi Magota; Katsuhiko Kasai; Yuji Kuge; Hiroki Shirato; Nagara Tamaki
Journal:  J Nucl Med       Date:  2013-01-15       Impact factor: 10.057

5.  18F-EF5: a new PET tracer for imaging hypoxia in head and neck cancer.

Authors:  Gaber Komar; Marko Seppänen; Olli Eskola; Paula Lindholm; Tove J Grönroos; Sarita Forsback; Hannu Sipilä; Sydney M Evans; Olof Solin; Heikki Minn
Journal:  J Nucl Med       Date:  2008-11-07       Impact factor: 10.057

6.  Tumors exposed to acute cyclic hypoxic stress show enhanced angiogenesis, perfusion and metastatic dissemination.

Authors:  Einar K Rofstad; Jon-Vidar Gaustad; Tormod A M Egeland; Berit Mathiesen; Kanthi Galappathi
Journal:  Int J Cancer       Date:  2010-10-01       Impact factor: 7.396

7.  Prognostic value of tumour blood flow, [¹⁸F]EF5 and [¹⁸F]FDG PET/CT imaging in patients with head and neck cancer treated with radiochemotherapy.

Authors:  Gaber Komar; Kaisa Lehtiö; Marko Seppänen; Olli Eskola; Helena Levola; Paula Lindholm; Hannu Sipilä; Jan Seppälä; Reidar Grénman; Olof Solin; Heikki Minn
Journal:  Eur J Nucl Med Mol Imaging       Date:  2014-06-05       Impact factor: 9.236

8.  The pervasive presence of fluctuating oxygenation in tumors.

Authors:  Laura I Cárdenas-Navia; Daniel Mace; Rachel A Richardson; David F Wilson; Siqing Shan; Mark W Dewhirst
Journal:  Cancer Res       Date:  2008-07-15       Impact factor: 12.701

9.  A modeling approach for quantifying tumor hypoxia with [F-18]fluoromisonidazole PET time-activity data.

Authors:  J J Casciari; M M Graham; J S Rasey
Journal:  Med Phys       Date:  1995-07       Impact factor: 4.071

10.  Repeatability of tumour hypoxia imaging using [18F]EF5 PET/CT in head and neck cancer.

Authors:  Antti Silvoniemi; Sami Suilamo; Timo Laitinen; Sarita Forsback; Eliisa Löyttyniemi; Samuli Vaittinen; Virva Saunavaara; Olof Solin; Tove J Grönroos; Heikki Minn
Journal:  Eur J Nucl Med Mol Imaging       Date:  2017-10-26       Impact factor: 9.236
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.